Mn-MOF effectively reshapes the tumor immune microenvironment under US irradiation by increasing activated CD8+ T cell numbers and mature DCs and reducing the number of MDSCs in tumor tissue, with strong potential as an advanced hypoxic cancer therapy system [105]. The gene discussed is CD8A; the disease is neoplasm.